Takada A - Search Results

1

Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.

Sakata K, Miura F, Sugino H, Shinobe M, Shirotani M, Yoshida H, Mori N, Hoshino T, Takada A. Sakata K, et al. Among authors: takada a. Am Heart J. 1996 Jan;131(1):1-6. doi: 10.1016/s0002-8703(96)90043-5. Am Heart J. 1996. PMID: 8553994

2

Characteristics of vasospastic angina with exercised-induced ischemia--analysis of parameters of hemostasis and fibrinolysis.

Sakata K, Hoshino T, Yoshida H, Shugino H, Miura F, Takada A. Sakata K, et al. Among authors: takada a. Jpn Circ J. 1996 May;60(5):277-84. doi: 10.1253/jcj.60.277. Jpn Circ J. 1996. PMID: 8803721 Free article.

3

Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension.

Sakata K, Shirotani M, Yoshida H, Urano T, Takada Y, Takada A. Sakata K, et al. Among authors: takada a, takada y. Am Heart J. 1999 Jun;137(6):1094-9. doi: 10.1016/s0002-8703(99)70368-6. Am Heart J. 1999. PMID: 10347337 Clinical Trial.

4

Effects of a long-term pharmacological interruption of the renin-angiotensin system on the fibrinolytic system in essential hypertension.

Sakata K, Pawlak R, Urano T, Takada A. Sakata K, et al. Among authors: takada a. Pathophysiol Haemost Thromb. 2002 Mar-Apr;32(2):67-75. doi: 10.1159/000065078. Pathophysiol Haemost Thromb. 2002. PMID: 12214151 Free article. Clinical Trial.

5

Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemia.

Sakata K, Kurata C, Taguchi T, Suzuki S, Kobayashi A, Yamazaki N, Rydzewski A, Takada Y, Takada A. Sakata K, et al. Among authors: takada a, takada y. Am Heart J. 1990 Oct;120(4):831-8. doi: 10.1016/0002-8703(90)90198-7. Am Heart J. 1990. PMID: 2220535

6

The role of the fibrinolytic system in acute myocardial infarction after a normal exercise test.

Sakata K, Kurata C, Taguchi T, Hayashi H, Kobayashi A, Yamazaki N, Rydzewski A, Takada A. Sakata K, et al. Among authors: takada a. Eur Heart J. 1989 Dec;10(12):1118-22. doi: 10.1093/oxfordjournals.eurheartj.a059436. Eur Heart J. 1989. PMID: 2514101

7

Effects of beraprost sodium, a new prostaglandin I2 analog, on parameters of hemostasis, fibrinolysis, and myocardial ischemia in patients with exertional angina.

Sakata K, Hoshino T, Yoshida H, Kaburagi T, Takada A. Sakata K, et al. Among authors: takada a. Cardiovasc Drugs Ther. 1995 Aug;9(4):601-7. doi: 10.1007/BF00878093. Cardiovasc Drugs Ther. 1995. PMID: 8547211 Clinical Trial.

8

Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery.

Sakata K, Miho N, Shirotani M, Yoshida H, Takada Y, Takada A. Sakata K, et al. Among authors: takada a, takada y. Atherosclerosis. 1998 Feb;136(2):225-31. doi: 10.1016/s0021-9150(97)00209-8. Atherosclerosis. 1998. PMID: 9543092

9

Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during amlodipine treatment of hypertension in Japanese patients.

Ahaneku JE, Sakata K, Urano T, Takada Y, Takada A. Ahaneku JE, et al. Among authors: takada a, takada y. Pharmacol Res. 2000 Jan;41(1):75-9. doi: 10.1006/phrs.1999.0557. Pharmacol Res. 2000. PMID: 10600272

10

Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during treatment of hypertension with cilnidipine.

Ahaneku JE, Sakata K, Urano T, Takada Y, Takada A. Ahaneku JE, et al. Among authors: takada a, takada y. Pharmacol Res. 2000 Jan;41(1):81-4. doi: 10.1006/phrs.1999.0558. Pharmacol Res. 2000. PMID: 10600273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,229 results

Search Page

Filters